BNR
Burning Rock Biotech
21 hedge funds and large institutions have $15.8M invested in Burning Rock Biotech in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.36% more ownership
Funds ownership: 2.49% → 2.85% (+0.36%)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
21
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.2M | |
| 2 | +$82.8K | |
| 3 | +$38.2K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$5.4K |
| 5 |
Morgan Stanley
New York
|
+$2.02K |
Top Sellers
| 1 | -$190K | |
| 2 | -$74.3K | |
| 3 | -$19K | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$18K |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$18K |